• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态深度学习挖掘肝内胆管癌病理图像中可解释的预后特征。

Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning.

机构信息

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, No.180, Feng Lin Road, Shanghai, 200032, China.

School of Computer Science, Shanghai Key Laboratory of Intelligent Information Processing, Fudan University, No.2005, Song Hu Road, Shanghai, 200433, China.

出版信息

BMC Med. 2024 Jul 8;22(1):282. doi: 10.1186/s12916-024-03482-0.

DOI:10.1186/s12916-024-03482-0
PMID:38972973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11229270/
Abstract

BACKGROUND

The advances in deep learning-based pathological image analysis have invoked tremendous insights into cancer prognostication. Still, lack of interpretability remains a significant barrier to clinical application.

METHODS

We established an integrative prognostic neural network for intrahepatic cholangiocarcinoma (iCCA), towards a comprehensive evaluation of both architectural and fine-grained information from whole-slide images. Then, leveraging on multi-modal data, we conducted extensive interrogative approaches to the models, to extract and visualize the morphological features that most correlated with clinical outcome and underlying molecular alterations.

RESULTS

The models were developed and optimized on 373 iCCA patients from our center and demonstrated consistent accuracy and robustness on both internal (n = 213) and external (n = 168) cohorts. The occlusion sensitivity map revealed that the distribution of tertiary lymphoid structures, the geometric traits of the invasive margin, the relative composition of tumor parenchyma and stroma, the extent of necrosis, the presence of the disseminated foci, and the tumor-adjacent micro-vessels were the determining architectural features that impacted on prognosis. Quantifiable morphological vector extracted by CellProfiler demonstrated that tumor nuclei from high-risk patients exhibited significant larger size, more distorted shape, with less prominent nuclear envelope and textural contrast. The multi-omics data (n = 187) further revealed key molecular alterations left morphological imprints that could be attended by the network, including glycolysis, hypoxia, apical junction, mTORC1 signaling, and immune infiltration.

CONCLUSIONS

We proposed an interpretable deep-learning framework to gain insights into the biological behavior of iCCA. Most of the significant morphological prognosticators perceived by the network are comprehensible to human minds.

摘要

背景

基于深度学习的病理图像分析技术的进步为癌症预后预测提供了新的见解。然而,缺乏可解释性仍然是其临床应用的一个重大障碍。

方法

我们建立了一个用于肝内胆管癌(iCCA)的综合预后神经网络,以全面评估全切片图像的结构和细粒度信息。然后,利用多模态数据,我们对模型进行了广泛的询问式分析,以提取和可视化与临床结果和潜在分子改变最相关的形态特征。

结果

该模型是在我们中心的 373 名 iCCA 患者中开发和优化的,在内部(n=213)和外部(n=168)队列中均表现出一致的准确性和稳健性。遮挡敏感图显示,三级淋巴结构的分布、浸润边缘的几何特征、肿瘤实质和基质的相对组成、坏死程度、弥散灶的存在以及肿瘤相邻的微血管是影响预后的决定性结构特征。CellProfiler 提取的可量化形态向量表明,高危患者的肿瘤细胞核体积显著增大,形状更不规则,核膜和纹理对比度减小。来自 187 名患者的多组学数据进一步揭示了关键的分子改变在形态学上留下的印记,这些印记可以被网络所关注,包括糖酵解、缺氧、顶端连接、mTORC1 信号和免疫浸润。

结论

我们提出了一种可解释的深度学习框架,以深入了解 iCCA 的生物学行为。网络感知到的大多数重要形态预后因素都是可以被人类理解的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/49295e2495bb/12916_2024_3482_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/3a8463f6a732/12916_2024_3482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/79a8807b48ee/12916_2024_3482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/f2bd94b9b699/12916_2024_3482_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/49295e2495bb/12916_2024_3482_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/3a8463f6a732/12916_2024_3482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/79a8807b48ee/12916_2024_3482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/f2bd94b9b699/12916_2024_3482_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a36/11229270/49295e2495bb/12916_2024_3482_Fig5_HTML.jpg

相似文献

1
Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning.多模态深度学习挖掘肝内胆管癌病理图像中可解释的预后特征。
BMC Med. 2024 Jul 8;22(1):282. doi: 10.1186/s12916-024-03482-0.
2
Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.全面分析基因组突变特征和肿瘤突变负担对肝内胆管癌预后的影响。
BMC Cancer. 2021 Feb 3;21(1):112. doi: 10.1186/s12885-021-07788-7.
3
Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features.深度学习在肝脏肿瘤诊断中的应用 Ⅱ:利用影像学特征进行卷积神经网络解释。
Eur Radiol. 2019 Jul;29(7):3348-3357. doi: 10.1007/s00330-019-06214-8. Epub 2019 May 15.
4
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.三级淋巴结构的分布和密度可预测肝内胆管癌的临床结局。
J Hepatol. 2022 Mar;76(3):608-618. doi: 10.1016/j.jhep.2021.10.030. Epub 2021 Nov 15.
5
Preoperative prediction of textbook outcome in intrahepatic cholangiocarcinoma by interpretable machine learning: A multicenter cohort study.通过可解释机器学习对肝内胆管癌教科书式预后进行术前预测:一项多中心队列研究
World J Gastroenterol. 2025 Mar 21;31(11):100911. doi: 10.3748/wjg.v31.i11.100911.
6
Correlation of Vein-Rich Tumor Microenvironment of Intrahepatic Cholangiocarcinoma With Tertiary Lymphoid Structures and Patient Outcome.肝内胆管癌富含静脉的肿瘤微环境与三级淋巴结构的相关性及其与患者预后的关系。
Mod Pathol. 2024 Feb;37(2):100401. doi: 10.1016/j.modpat.2023.100401. Epub 2023 Dec 1.
7
Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.肝内胆管细胞癌肉瘤样变患者的临床特征及手术切除后的预后:倾向评分匹配分析。
J Surg Oncol. 2020 Mar;121(3):524-537. doi: 10.1002/jso.25815. Epub 2019 Dec 22.
8
Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.整合分析揭示了肝内胆管癌亚型的不同特征。
Liver Int. 2024 Sep;44(9):2477-2493. doi: 10.1111/liv.16015. Epub 2024 Jun 25.
9
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.多模块分析肝内胆管癌免疫亚群揭示了不同的治疗弱点。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004892.
10
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.世界卫生组织肝内胆管癌亚型分类的外科解读:一篇综述
Surg Today. 2025 Jan;55(1):1-9. doi: 10.1007/s00595-024-02825-x. Epub 2024 Apr 2.

引用本文的文献

1
An Artificial Intelligence Pipeline for Hepatocellular Carcinoma: From Data to Treatment Recommendations.一种用于肝细胞癌的人工智能流程:从数据到治疗建议
Int J Gen Med. 2025 Jul 2;18:3581-3595. doi: 10.2147/IJGM.S529322. eCollection 2025.
2
Advances and challenges in pathomics for liver cancer: From diagnosis to prognostic stratification.肝癌病理组学的进展与挑战:从诊断到预后分层
World J Clin Oncol. 2025 Jun 24;16(6):107646. doi: 10.5306/wjco.v16.i6.107646.
3
Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma.

本文引用的文献

1
Targeting the tumor stroma for cancer therapy.针对肿瘤基质的癌症治疗。
Mol Cancer. 2022 Nov 2;21(1):208. doi: 10.1186/s12943-022-01670-1.
2
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.肝内胆管癌治疗进展:临床医生当前及未来治疗前景概述
CA Cancer J Clin. 2023 Mar;73(2):198-222. doi: 10.3322/caac.21759. Epub 2022 Oct 19.
3
A comprehensive study of p53 protein.对p53蛋白的全面研究。
基于MRI和CT的深度学习放射组学分析及其联合用于诊断肝内胆管癌的比较
Sci Rep. 2025 Mar 20;15(1):9629. doi: 10.1038/s41598-025-92263-7.
J Cell Biochem. 2022 Dec;123(12):1891-1937. doi: 10.1002/jcb.30331. Epub 2022 Oct 2.
4
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.多模块分析肝内胆管癌免疫亚群揭示了不同的治疗弱点。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004892.
5
Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma.人工智能在肝细胞癌的预防和临床管理中的应用。
J Hepatol. 2022 Jun;76(6):1348-1361. doi: 10.1016/j.jhep.2022.01.014.
6
Explainable artificial intelligence (XAI) in deep learning-based medical image analysis.深度学习在医学影像分析中的可解释人工智能(XAI)。
Med Image Anal. 2022 Jul;79:102470. doi: 10.1016/j.media.2022.102470. Epub 2022 May 4.
7
Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma.单细胞转录组分析提示肝内胆管癌存在两种分子亚型。
Nat Commun. 2022 Mar 28;13(1):1642. doi: 10.1038/s41467-022-29164-0.
8
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.人工智能驱动的肿瘤浸润淋巴细胞空间分析作为非小细胞肺癌免疫检查点抑制的补充生物标志物
J Clin Oncol. 2022 Jun 10;40(17):1916-1928. doi: 10.1200/JCO.21.02010. Epub 2022 Mar 10.
9
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.蛋白质基因组学特征鉴定出肝内胆管癌的临床相关亚组。
Cancer Cell. 2022 Jan 10;40(1):70-87.e15. doi: 10.1016/j.ccell.2021.12.006. Epub 2021 Dec 30.
10
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.三级淋巴结构的分布和密度可预测肝内胆管癌的临床结局。
J Hepatol. 2022 Mar;76(3):608-618. doi: 10.1016/j.jhep.2021.10.030. Epub 2021 Nov 15.